N‐Acetylcysteine Improves the Clinical Conditions of Mustard Gas‐Exposed Patients with Normal Pulmonary Function Test
: Administration of N‐acetylcysteine may be effective in diseases caused by oxidative–antioxidative imbalance. We aimed to determine the effect administration for 4 months of N‐acetylcysteine (1200 mg daily) on sulfur mustard‐induced bronchiolitis obliterans in patients with normal pulmonary functi...
Gespeichert in:
Veröffentlicht in: | Basic & clinical pharmacology & toxicology 2008-11, Vol.103 (5), p.428-432 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | : Administration of N‐acetylcysteine may be effective in diseases caused by oxidative–antioxidative imbalance. We aimed to determine the effect administration for 4 months of N‐acetylcysteine (1200 mg daily) on sulfur mustard‐induced bronchiolitis obliterans in patients with normal pulmonary function test. In a double‐blind clinical trial, 144 patients with bronchiolitis obliterans due to sulfur mustard and bronchiolitis obliterans syndrome class 0, randomly entered to group 1 (n = 72, N‐acetylcysteine) and group 2 (n = 72, placebo). The changes in dyspnoea, wake‐up dyspnoea, cough and sputum were measured after 4 months using a ‘delta value’ (i.e. symptom score after 4 months – symptom score before the trial). Spirometric findings were measured at the beginning of the trial, 2 months later and 4 months later. Dyspnoea (delta value: –0.78 (0.61), P |
---|---|
ISSN: | 1742-7835 1742-7843 |
DOI: | 10.1111/j.1742-7843.2008.00318.x |